Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,972 | 359 | 99.2% |
| Education | $31.90 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $941.89 | 88 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $521.75 | 34 | $0 (2024) |
| Alkermes, Inc. | $466.26 | 30 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $413.06 | 33 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $291.66 | 39 | $0 (2019) |
| Allergan Inc. | $276.43 | 65 | $0 (2019) |
| Indivior Inc. | $228.95 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $206.47 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $176.45 | 12 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $137.68 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $578.47 | 42 | ABBVIE INC. ($188.02) |
| 2023 | $798.77 | 62 | AbbVie Inc. ($373.07) |
| 2022 | $590.46 | 49 | ABBVIE INC. ($341.25) |
| 2021 | $57.92 | 4 | AbbVie Inc. ($39.55) |
| 2020 | $151.21 | 11 | Otsuka America Pharmaceutical, Inc. ($36.08) |
| 2019 | $715.77 | 86 | Otsuka America Pharmaceutical, Inc. ($138.85) |
| 2018 | $613.70 | 75 | Otsuka America Pharmaceutical, Inc. ($122.61) |
| 2017 | $498.09 | 32 | Alkermes, Inc. ($137.27) |
All Payment Transactions
361 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Neuropsychiatry | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Neurology | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ANTI-ANXIETY | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Neuropsychiatry | ||||||
| 07/23/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: CNS | ||||||
| 07/02/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Neuroscience | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Neurology | ||||||
| 06/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Neuroscience | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: BH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 75 | 308 | $64,100 | $15,491 |
| 2022 | 1 | 84 | 388 | $77,600 | $19,393 |
| 2021 | 1 | 96 | 461 | $92,200 | $25,650 |
| 2020 | 2 | 113 | 460 | $94,750 | $25,686 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 308 | $64,100 | $15,491 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 388 | $77,600 | $19,393 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 461 | $92,200 | $25,650 | 27.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 449 | $89,800 | $24,291 | 27.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 11 | 11 | $4,950 | $1,395 | 28.2% |
About Dr. Robert Bennett, MD
Dr. Robert Bennett, MD is a Psychiatry healthcare provider based in Aberdeen, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225102346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Bennett, MD has received a total of $4,004 in payments from pharmaceutical and medical device companies, with $578.47 received in 2024. These payments were reported across 361 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,972).
As a Medicare-enrolled provider, Bennett has provided services to 368 Medicare beneficiaries, totaling 1,617 services with total Medicare billing of $86,220. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Aberdeen, NJ
- Active Since 11/20/2006
- Last Updated 09/06/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1225102346
Products in Payments
- VRAYLAR (Drug) $1,218
- INVEGA SUSTENNA (Drug) $323.07
- LATUDA (Drug) $291.66
- REXULTI (Drug) $252.48
- INGREZZA (Drug) $206.47
- PERSERIS (Drug) $200.03
- ABILIFY MAINTENA (Drug) $192.02
- Aristada 441 mg (Drug) $155.35
- CAPLYTA (Drug) $148.29
- Fanapt (Drug) $122.98
- ARISTADA (Drug) $120.42
- SPRAVATO (Drug) $107.74
- Vivitrol 380 mg (Drug) $97.92
- INVEGA TRINZA (Drug) $90.94
- AUSTEDO (Drug) $67.04
- UZEDY (Drug) $66.94
- VIVITROL (Drug) $58.10
- Trintellix (Drug) $42.72
- Austedo XR (Drug) $42.47
- Vivitrol (Drug) $34.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Aberdeen
Ms. Sahar Awad, Md, MD
Psychiatry — Payments: $12,156
Mr. Maher Awad, Md, MD
Psychiatry — Payments: $11,008
Hina Aamir, M.d, M.D
Psychiatry — Payments: $4,489
Dr. Chandrika Nadipuram, M.d, M.D
Psychiatry — Payments: $3,452
Ranjana Verma, M.d, M.D
Psychiatry — Payments: $3,402
Dr. Shawn Cassady, M.d, M.D
Psychiatry — Payments: $2,641